Closed
SectorHealthcare
1.75 -3.31
24h
Min
1.75
Max
1.77
Income | -38M -116M |
---|---|
Sales | -24M 49M |
EPS | -0.36 |
Profit margin | -235.51 |
Employees | 838 |
EBITDA | -35M -110M |
Recommendations | Buy |
---|---|
12 Months Forecast | +555.74% upside |
Next Earnings | 7 sie 2025 |
---|
Market Cap | -574M 594M |
---|---|
Previous open | 5.06 |
Previous close | 1.75 |
By Acuity
50%
50%
151 / 381 Ranking in Healthcare
By Trading Central
Confidence
Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 12 USD 555.74%
High 25 USD
Low 2 USD
Based on 14 Wall Street analysts offering 12 month price targets forIovance Biotherapeutics Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$